| Literature DB >> 25676326 |
Hyung Jun Noh1, Hyo Hyun Yang2,3, Geum Soog Kim1, Seung Eun Lee1, Dae Young Lee1, Je Hun Choi1, Seung Yu Kim1, Eun Suk Lee1, Seung Heon Ji1, Ki Sung Kang4, Hye-Jin Park5, Jae-Ryong Kim2,3, Ki Hyun Kim6.
Abstract
Hericium erinaceum is an edible and medicinal mushroom widely used in Korea, Japan, and China. On the search for biologically active compounds supporting the medicinal usage, the MeOH extract of the fruiting bodies of H. erinaceum was investigated for its chemical constituents. Six compounds were isolated and identified as hericenone D (1), (22E,24R)-5α,8α-epidioxyergosta-6,22-dien-3β-ol (2), erinacerin B (3), hericenone E (4), hericenone F (5) and isohericerin (6) by comparing their spectroscopic data with previously reported values. The inhibitory effects on adriamycin-induced cellular senescence in human dermal fibroblasts (HDFs) and human umbilical vein endothelial cells (HUVECs) of the isolates (1-6) were studied. Among the isolated compounds, ergosterol peroxide (2) reduced senescence associated β-galactosidase (SA-β-gal) activity increased in HUVECs treated with adriamycin. According to experimental data obtained, the active compound may inspire the development of a new pharmacologically useful substance to be used in the treatment and prevention of age-related diseases.Entities:
Keywords: Ergosterol peroxide; Hericium erinaceum; human dermal fibroblasts; human umbilical vein endothelial cells; senescence associated β-galactosidase activity
Mesh:
Substances:
Year: 2015 PMID: 25676326 DOI: 10.3109/14756366.2014.995181
Source DB: PubMed Journal: J Enzyme Inhib Med Chem ISSN: 1475-6366 Impact factor: 5.051